From Financial Modeling Prep: 2025-03-26 07:00:00

Hologic, Inc. is a key player in medical technology, focusing on women’s health and diagnostics. Their ROIC of 10.04% shows efficient capital use. ResMed Inc. leads with a 20.06% ROIC and a 2.69 ROIC to WACC ratio. Henry Schein, Inc. and DENTSPLY SIRONA Inc. lag with ROIC to WACC ratios below 1, signaling lower efficiency.



Read more at Financial Modeling Prep:: Hologic, Inc. (NASDAQ:HOLX) Financial Performance …